|
|
|
Genetic Technologies Limited (GENE) |
|
Genetic Technologies Limited
GENE's Fundamental analysis
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
|
Genetic Technologies Limited's sales fell
by -86.56 % in IV. Quarter 2019 from the same quarter a year ago.
Biotechnology & Pharmaceuticals industry recorded
growth of revenues by 1.17 %
• More on GENE's Growth
|
|
Genetic Technologies Limited
reported net loss of -6 millions in the past twelve months.
|
| Company |
| |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.87.
• More on GENE's Valuation
|
|
|
|
|
Genetic Technologies Limited
reported net loss of -6 millions in the past twelve months.
|
| Company |
| |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.87.
| | | |
